We Hope to See You at AUA2017!

The American Urological Association’s 2017 Annual Meeting is just around the corner. This annual event provides the ideal platform for thought leaders in the field to explore the latest advances in urologic medicine. Attendees from around the globe will gather in Boston, Massachusetts, May 12 – 16, for the 112th AUA Annual Meeting. Last year’s meeting attracted more than 16,000 attendees, from 111 countries, a testament to its significance in the international urologic medical community.

Connect with GenPath at Booth 904

At GenPath, we are gearing up for AUA2017 and we hope to see you there! Be sure to visit our booth to learn more about the larger impact of the 4Kscore. Connect with our team and get answers to your questions.

Join us throughout the week for talks and symposiums including:

Advancements in Prostate Cancer Diagnostics: Genetic Testing & 4Kscore

Attendees will learn about an exciting development from our genetics division, GeneDx; a new panel that tests for hereditary prostate cancer genes to help patients understand their genetic risk for the disease and clinicians make management decisions. We will also explore how the 4Kscore and genetic testing can fit into the urology practice.

  • Speakers:
    • Benjamin D. Solomon, MD, FACMG – Managing Director, GeneDx
    • Sanoj Punnen, MD, MAS – Assistant Professor of Urologic Oncology, University of Miami, Miller School of Medicine and Sylvester Comprehensive Cancer Center
    • Mitchell Steiner, MD, FACS – Moderator
  • Date: Sunday, May 14, 2017
  • Time: 10:00AM – 11:00AM
  • Location: ICU Theatre – Booth 1354

Pre-register today!

4Kscore: An Actionable Biomarker in an Era of Accountable Care

Attendees will learn more about 4Kscore and how their patients will benefit from the test.

  • Speaker: Dr. Steve Zappala
  • Dates/Times: Saturday 5/13 and Monday 5/15 at 10:30AM
  • Location: Booth 904

GeneDx: Supporting Urologists in the Evaluation of Hereditary Prostate Cancer through Genetic Testing

Attendees will discover how genetic testing can easily fit into a Urologist’s practice and inform medical management.

  • Speaker: Lance Grau (Genetic Counselor for GeneDx)
  • Dates/Times: Saturday 5/13, Sunday 5/14, and Monday 5/15 at 12:30PM
  • Location: Booth 904

The Role of 4Kscore and Multiparametric MRI for Diagnosing Aggressive Prostate Cancer

Attendees will learn how Urologists are combining the 4Kscore and MRI in the evaluation of men suspected of having aggressive prostate cancer.

  • Speaker: Dr. Jay Newmark
  • Dates/Times: Saturday 5/13, Sunday 5/14, and Monday 5/15 at 2:30PM
  • Location: Booth 904

Discover More About the 4Kscore at AUA2017

Not only will we be sponsoring a booth and hosting a number of talks, the 4Kscore will also be featured in AUA Curriculum by independent physicians. Do not miss your chance to learn more about the vital role the 4Kscore is playing in modern urologic medicine.

The 4Kscore Test Accurately Predicts Aggressive Prostate Cancer in Men of all Ages and Race

  • Date: Friday, May 12, 2017
  • Time: 9:30AM

A four-kallikrein panel in predicting high-grade prostate cancer on biopsy: an independent replication from the Finnish section of the European Randomized Study of Screening for Prostate Cancer

  • Date: Sunday, May 14, 2017
  • Time: 10:20AM

Combining 4Kscore and MRI for Prostate Biopsy Decision Making

  • Date: Sunday, May 14, 2017
  • Time: 10:40AM

Does 4K and/or Michigan Prostate Score Change Cancer Detection Rates in Multi-Parametric MRI discovered PIRADS 3 or Lower Lesions

  • Date: Tuesday, May 16, 2017
  • Time: 8:20AM

An Independent, Multi-Institutional, Prospective study in the Veterans Affairs Health System confirms the 4Kscore accurately predicts aggressive prostate cancer

  • Date: Tuesday, May 16, 2017
  • Time: 10:00AM

Ready to Learn More About the 4Kscore?

Will you be attending AUA2017? If so, we encourage you to visit our booth and to take in the symposiums and talks outlined above. If you will not be attending this year’s meeting, be sure to connect with us on Facebook, Twitter, Google+ and LinkedIn. Stay in-the-know about the exciting advancements in urological medicine that will be announced at this year’s meeting. Join in the conversation!

 

GenPath is a division of BioReference Laboratories, Inc.